Imperial College London Diabetes Centre, a Mubadala Health partner, is a state-of-the-art, out-patient facility specialising in diabetes treatment, research, training and public health awareness.
In just over a decade, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.
ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates three branches across Abu Dhabi and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives.
Imperial College London Diabetes Centre has developed a specific approach to diabetes care, based on the particular needs of Abu Dhabi, UAE and the wider region, and offers the highest level of specialised patient care from first diagnosis to the management of diabetes and all associated complications.
Under the patronage of Her Highness Sheikha Fatima bint Mubarak, Imperial College London Diabetes Centre has developed a community resource, Diabetes.Knowledge.Action, now the longest running public health awareness campaign in the country. The campaign promotes public health lifestyle activities and events around balanced diet, maintaining healthy body weight and engaging in daily exercise routines. Major activations include the annual walkathon coinciding with World Diabetes Day in November.
Training and Education
Education is one of the four key pillars in the Centre’s approach to tackle diabetes. The Centre organises specialist conferences accredited for Continuing Medical Education (CME) credits for healthcare professionals, as well as weekly in-house seminars for resident doctors.
Imperial College London Diabetes Centre encompasses epidemiological, basic, clinical and genetic research focusing on diabetes in the UAE, as well as general surveys amongst the public who take part in our campaign activities. The research is world-class, particularly directed to explaining the high prevalence of diabetes and obesity in the country, aiming to find mechanisms to slow down and reverse the trend.